These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36839824)

  • 1. Chitosan-Based Nanoparticles with Optimized Parameters for Targeted Delivery of a Specific Anticancer Drug-A Comprehensive Review.
    Kurczewska J
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.
    Yu X; Hou J; Shi Y; Su C; Zhao L
    Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based nanodelivery systems for cancer therapy: Recent advances.
    Narmani A; Jafari SM
    Carbohydr Polym; 2021 Nov; 272():118464. PubMed ID: 34420724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review.
    Elkomy MH; Ali AA; Eid HM
    J Control Release; 2022 Nov; 351():923-940. PubMed ID: 36216174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan magnetic nanoparticles for drug delivery systems.
    Assa F; Jafarizadeh-Malmiri H; Ajamein H; Vaghari H; Anarjan N; Ahmadi O; Berenjian A
    Crit Rev Biotechnol; 2017 Jun; 37(4):492-509. PubMed ID: 27248312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment.
    Choukaife H; Seyam S; Alallam B; Doolaanea AA; Alfatama M
    Int J Nanomedicine; 2022; 17():3933-3966. PubMed ID: 36105620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells.
    Li PW; Wang G; Yang ZM; Duan W; Peng Z; Kong LX; Wang QH
    Drug Deliv; 2016; 23(1):30-5. PubMed ID: 24712731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
    Islam N; Ferro V
    Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review.
    Wang G; Li R; Parseh B; Du G
    Carbohydr Polym; 2021 Sep; 268():118192. PubMed ID: 34127212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
    Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment.
    Sharifi-Rad J; Quispe C; Butnariu M; Rotariu LS; Sytar O; Sestito S; Rapposelli S; Akram M; Iqbal M; Krishna A; Kumar NVA; Braga SS; Cardoso SM; Jafernik K; Ekiert H; Cruz-Martins N; Szopa A; Villagran M; Mardones L; Martorell M; Docea AO; Calina D
    Cancer Cell Int; 2021 Jun; 21(1):318. PubMed ID: 34167552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc Modified Nanotransporter of Anticancer Drugs for Targeted Therapy: Biophysical Analysis.
    Skalickova S; Docekalova M; Stankova M; Uhlirova D; Ruttkay-Nedecky B; Fernandez C; Kepinska M; Milnerowicz H; Kizek R
    J Nanosci Nanotechnol; 2019 May; 19(5):2483-2488. PubMed ID: 30501743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
    Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-Based Nanoparticles as Effective Drug Delivery Systems-A review.
    Jafernik K; Ładniak A; Blicharska E; Czarnek K; Ekiert H; Wiącek AE; Szopa A
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan: a propitious biopolymer for drug delivery.
    Duttagupta DS; Jadhav VM; Kadam VJ
    Curr Drug Deliv; 2015; 12(4):369-81. PubMed ID: 25761010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.
    Khdair A; Hamad I; Alkhatib H; Bustanji Y; Mohammad M; Tayem R; Aiedeh K
    Eur J Pharm Sci; 2016 Oct; 93():38-44. PubMed ID: 27473308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
    Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
    Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.